This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? blogs or webinars). From FDA guidelines to Googles ad policies , failure to comply can result in ad disapprovals, fines, or reputational damage.
Digital Referral Campaigns Platforms like eHealthcare Solutions offer HIPAA-compliant digital advertising that can amplify referral messaging. Whether its a shared testimonial or HCP blog post, digital content should encourage word-of-mouth amplification while respecting patient privacy. Yes, but it requires careful execution.
Regulatory Constraints HIPAA, GDPR, and FDA guidelines shape how leads are collected, stored, and contacted. Leverage Owned and Operated Channels Use your brand website, blog, and educational portals to capture leads. A well-designed Lead Generation Network should accommodate multiple personas.
These often involve real patients who use branded medications such as Dupixent or Cosentyx sharing their journeys through video testimonials, blogs, or social media. Every message, endorsement, or testimonial must meet FDA, FTC, and local privacy regulations. Digital referral solutions are also on the rise. Yes, if properly executed.
GoodRx is alleged to have shared ostensibly protected personal health information with other tech companies, used the data for ad targeting, allowed third-party use of the data, used a HIPAA seal on its site that misrepresented its compliance status, and failed to put other policies in place to protect the data.
Blogs, whitepapers, webinars, and infographics can help position your brand as a trusted authority. Using FDA-approved messaging and ensuring transparent disclaimers are critical in avoiding regulatory issues. Brands must adhere to HIPAA, FDA, and GDPR guidelines when collecting and using patient data.
These tools: Generate SEO-friendly blog content on medical topics. Regulatory Compliance and Data Privacy Pharma marketing teams must ensure AI strategies comply with: HIPAA and GDPR regulations for patient data privacy. FDA guidelines on AI-generated content. Can AI help with FDA compliance in pharma marketing?
Branded drug names and generic alternatives should be included while following FDA advertising regulations. Pharma companies should use HIPAA-compliant programmatic platforms to avoid privacy risks. Marketers must ensure that ads meet FDA, GDPR, HIPAA, and other global regulations.
But as powerful as RTB is, pharma brands must navigate strict regulatory challenges to ensure compliance with FDA and GDPR guidelines. HIPAA and Patient Privacy Concerns RTB relies on user data for targeting, but in the pharma space, this raises serious privacy concerns. HIPAA, GDPR, and FDA regulations must be followed strictly.
Educational Content: Beyond promoting products, offer valuable resources like blogs, webinars, and infographics. Blogs optimized for keywords like “pharmaceutical marketing” or “innovative drug strategies” attract attention from both patients and HCPs.
It means using data responsibly to tailor content, recommend resources, and support adherenceall while complying with HIPAA and other healthcare regulations. Ad copy and landing pages must include ISI (Important Safety Information), follow FDA and PhRMA guidelines, and offer fair balance when promoting branded products.
And the memo goes one step more arguing that, even if otherwise truthful, promotion of off-label uses of hormones can run afoul of FDA prohibitions on misbranding and mislabeling. Nevertheless, individuals and organizations could be in receipt of grand jury or HIPAA subpoenas requesting records, or they could be visited by federal agents.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content